Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$35.79

0.4407 (1.25%)

10:50
04/06/18
04/06
10:50
04/06/18
10:50

AstraZeneca attracts bullish option flow as shares tick higher

AstraZeneca attracts bullish option flow as shares tick higher. The stock up 43c to $35.78 and May 37.5 calls trade across the exchanges from 50 to 57.5c per contract. More than 7K trade total against 226 open interest and the market lifted to 60 to 65c. Earnings due 5/18 and the same day as the May contract expires.

  • 14

    Apr

  • 23

    Apr

AZN AstraZeneca
$35.79

0.4407 (1.25%)

02/19/18
DBAB
02/19/18
NO CHANGE
DBAB
Buy
AstraZeneca approval de-risks lung cancer franchise, says Deutsche Bank
Deutsche Bank analyst Richard Parkes says FDA approval of Imfinzi for stage III unresectable lung cancer further de-risks AstraZeneca's lung cancer franchise. The analyst expects the Tagrisso/Imfinzi franchise to add over $4B in "incremental high margin sales" from lung cancer over the next four years. Although expected by investors, the approval comes one month sooner than anticipated, Parkes tells investors in a research note. AstraZeneca is the analyst's top pick in European pharma.
03/14/18
HCWC
03/14/18
NO CHANGE
Target $6
HCWC
Buy
Advaxis drug unlikely culprit of patient death, says H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered his price target for Advaxis (ADXS) to $6 from $23 after the FDA placed a clinical hold on the Phase 1/2 study investigating the combination of the company's axalimogene filolisbac and AstraZeneca's (AZN) durvalumab for the treatment of HPV-associated cervical and head and neck cancers. Based on its previous safety profile, axalimogene is unlikely to be the cause of death for this patient, Ramakanth tells investors in a research note. The analyst, however, notes that it would likely take several months before the FDA is able to reach a decision and lift the clinical hold. He anticipates a one-to-two quarter delay to the axal plus durva combination therapy program but keeps a Buy rating on Advaxis shares.
03/19/18
JEFF
03/19/18
UPGRADE
JEFF
Buy
AstraZeneca upgraded to Buy from Hold at Jefferies
Jefferies analyst Ian Hilliker upgraded AstraZeneca to Buy and raised his price target for the shares to 5,600p from 5,075p. The company is at a "turning point," Hilliker tells investors in a research note. He believes accelerating new product launches and improving margins should deliver over 20% core earnings growth in the mid-term. Recovering growth, driven by the underlying business warrants a "modest mid-term premium valuation," the analyst contends.
03/19/18
03/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Unilever (UN, UL) upgraded to Neutral from Sell at Goldman Sachs with the firm's analyst saying valuation reflects growth challenges. 2. AstraZeneca (AZN) upgraded to Buy from Hold at Jefferies with analyst Ian Hilliker saying the company is at a "turning point." 3. Dr Pepper Snapple (DPS) upgraded to Outperform from Sector Perform at RBC Capital saying that some investors have struggled to justify the strategic rationale of the company's Keurig deal, but he sees "several value creation drivers" including leverage in the growing coffee category, improvements for the core Keurig brand, and the prospects for higher cash flow conversion. 4. Oshkosh (OSK) upgraded to Buy from Hold while Cummins (CMI) upgraded to Hold from Sell at Deutsche Bank. 5. HarborOne Bancorp (HONE) upgraded to Buy from Hold at Sandler O'Neill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$284.67

2.87 (1.02%)

, SPX

S&P 500

$0.00

(0.00%)

13:19
08/16/18
08/16
13:19
08/16/18
13:19
Periodicals
U.S. and China to hold lower-level trade talks later in August, Reuters says »

A Chinese delegation …

SPY

SPDR S&P 500 ETF Trust

$284.67

2.87 (1.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:19
08/16/18
08/16
13:19
08/16/18
13:19
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/16/18
08/16
13:17
08/16/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/16/18
08/16
13:16
08/16/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRP

TransCanada

$43.81

0.04 (0.09%)

13:13
08/16/18
08/16
13:13
08/16/18
13:13
Periodicals
Federal judge orders review of Keystone XL oil pipeline, Reuters reports »

In the latest setback for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$23.39

0.92 (4.09%)

, MYL

Mylan

$37.94

0.12 (0.32%)

13:05
08/16/18
08/16
13:05
08/16/18
13:05
Hot Stocks
Teva granted FDA approval of first generic version of EpiPen »

The U.S. Food and Drug…

TEVA

Teva

$23.39

0.92 (4.09%)

MYL

Mylan

$37.94

0.12 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

GOOG

Alphabet

$1,223.00

9.35 (0.77%)

, GOOGL

Alphabet Class A

$1,239.00

6.7 (0.54%)

13:05
08/16/18
08/16
13:05
08/16/18
13:05
Periodicals
Google workers upset about company making censored engine for China, NYT says »

Hundreds of Google…

GOOG

Alphabet

$1,223.00

9.35 (0.77%)

GOOGL

Alphabet Class A

$1,239.00

6.7 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

13:04
08/16/18
08/16
13:04
08/16/18
13:04
Conference/Events
CFTC to hold a podcast on Agriculture Block Trade Analysis »

Dave Amato, of the U.S.…

HAFC

Hanmi Financial

$25.70

0.4 (1.58%)

13:04
08/16/18
08/16
13:04
08/16/18
13:04
Hot Stocks
Hanmi Financial announces receipt of all regulatory approvals for SWNB merger »

Hanmi Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CLF

Cleveland-Cliffs

$9.89

0.05 (0.51%)

13:00
08/16/18
08/16
13:00
08/16/18
13:00
Options
Repeat call spreads in Cleveland Cliffs »

Repeat call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

NWBI

Northwest Bancshares

$18.31

0.12 (0.66%)

13:00
08/16/18
08/16
13:00
08/16/18
13:00
Hot Stocks
Northwest Bancshares chairman William Wagner sells over 64K shares »

Northwest Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$23.47

1 (4.45%)

, MYL

Mylan

$37.84

0.02 (0.05%)

12:57
08/16/18
08/16
12:57
08/16/18
12:57
Hot Stocks
Teva rises, Mylan dips after FDA reported to approve first generic EpiPen »

Shares of Mylan (MYL)…

TEVA

Teva

$23.47

1 (4.45%)

MYL

Mylan

$37.84

0.02 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

MYL

Mylan

$37.85

0.03 (0.08%)

, TEVA

Teva

$23.45

0.975 (4.34%)

12:53
08/16/18
08/16
12:53
08/16/18
12:53
Periodicals
Breaking Periodicals news story on Mylan, Teva »

FDA approves Teva generic…

MYL

Mylan

$37.85

0.03 (0.08%)

TEVA

Teva

$23.45

0.975 (4.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

DE

Deere

$137.51

1.81 (1.33%)

12:51
08/16/18
08/16
12:51
08/16/18
12:51
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

NVDA

Nvidia

$260.13

1.15 (0.44%)

, AMAT

Applied Materials

$47.71

0.22 (0.46%)

12:51
08/16/18
08/16
12:51
08/16/18
12:51
Earnings
Notable companies reporting after market close »

Notable companies…

NVDA

Nvidia

$260.13

1.15 (0.44%)

AMAT

Applied Materials

$47.71

0.22 (0.46%)

JWN

Nordstrom

$51.81

-0.05 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

ADM

Archer Daniels

$50.05

0.62 (1.25%)

12:45
08/16/18
08/16
12:45
08/16/18
12:45
Recommendations
Archer Daniels analyst commentary  »

Archer Daniels price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

GOOG

Alphabet

$1,225.60

11.95 (0.98%)

, GOOGL

Alphabet Class A

$1,241.50

9.2 (0.75%)

12:38
08/16/18
08/16
12:38
08/16/18
12:38
Periodicals
Google preparing to launch display-equipped speaker for holiday season, NAR says »

Google (GOOGL) is…

GOOG

Alphabet

$1,225.60

11.95 (0.98%)

GOOGL

Alphabet Class A

$1,241.50

9.2 (0.75%)

AMZN

Amazon.com

$1,901.56

20.16 (1.07%)

BABA

Alibaba

$175.08

5.28 (3.11%)

AAPL

Apple

$213.46

3.18 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 22

    Aug

  • 23

    Aug

  • 10

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

SPY

SPDR S&P 500 ETF Trust

$285.01

3.21 (1.14%)

, SPX

S&P 500

$0.00

(0.00%)

12:33
08/16/18
08/16
12:33
08/16/18
12:33
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Mnuchin says U.S.…

SPY

SPDR S&P 500 ETF Trust

$285.01

3.21 (1.14%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$345.54

13.81 (4.16%)

12:32
08/16/18
08/16
12:32
08/16/18
12:32
Hot Stocks
Boeing to acquire Millennium Space Systems, terms not disclosed »

Boeing announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$23.83

0.17 (0.72%)

12:30
08/16/18
08/16
12:30
08/16/18
12:30
Options
One day option play opened in iShares MSCI Hong Kong Fund »

One day option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/16/18
08/16
12:17
08/16/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/16/18
08/16
12:16
08/16/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
08/16/18
08/16
12:15
08/16/18
12:15
General news
Atlanta Fed's Q3 GPNow estimate was held at 4.3% »

Atlanta Fed's Q3…

CMG

Chipotle

$525.43

-0.44 (-0.08%)

12:14
08/16/18
08/16
12:14
08/16/18
12:14
Periodicals
Chipotle finds cause of foodborne illness at Ohio location, CNBC says »

Chipotle said that tests…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

TIF

Tiffany

$127.95

2.23 (1.77%)

, BABA

Alibaba

$175.17

5.37 (3.16%)

12:13
08/16/18
08/16
12:13
08/16/18
12:13
Periodicals
Tiffany to sell on Alibaba's 'Luxury Pavilion' platform on Tmall, Axios reports »

Tiffany & Co (TIF)…

TIF

Tiffany

$127.95

2.23 (1.77%)

BABA

Alibaba

$175.17

5.37 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 10

    Sep

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.